Search

Kevin S. Orwig

Examiner (ID: 12620, Phone: (571)270-5869 , Office: P/1611 )

Most Active Art Unit
1611
Art Unit(s)
1658, 1611, 3991
Total Applications
922
Issued Applications
259
Pending Applications
54
Abandoned Applications
612

Applications

Application numberTitle of the applicationFiling DateStatus
18/083665 ANTIBODIES TO THE C3D FRAGEMENT OF COMPLEMENT COMPONENT 3 Dec 18, 2022 Abandoned
Array ( [id] => 20384752 [patent_doc_number] => RE050682 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-12-02 [patent_title] => Immunoglobulin variable domains [patent_app_type] => reissue [patent_app_number] => 18/062103 [patent_app_country] => US [patent_app_date] => 2022-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 112 [patent_figures_cnt] => 43 [patent_no_of_words] => 69763 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062103 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/062103
Immunoglobulin variable domains Dec 5, 2022 Issued
Array ( [id] => 20156250 [patent_doc_number] => RE050528 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-08-12 [patent_title] => Compounds and compositions for modulating EGFR mutant kinase activities [patent_app_type] => reissue [patent_app_number] => 18/057062 [patent_app_country] => US [patent_app_date] => 2022-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19599 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 496 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057062 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/057062
Compounds and compositions for modulating EGFR mutant kinase activities Nov 17, 2022 Issued
Array ( [id] => 20436780 [patent_doc_number] => RE050715 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-12-30 [patent_title] => Synthetic biochemistry molecular purge valve module that maintain co-factor balance [patent_app_type] => reissue [patent_app_number] => 18/052136 [patent_app_country] => US [patent_app_date] => 2022-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 8555 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18052136 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/052136
Synthetic biochemistry molecular purge valve module that maintain co-factor balance Nov 1, 2022 Issued
Array ( [id] => 20270073 [patent_doc_number] => RE050636 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-10-14 [patent_title] => Accurate molecular barcoding [patent_app_type] => reissue [patent_app_number] => 18/050449 [patent_app_country] => US [patent_app_date] => 2022-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 23 [patent_no_of_words] => 19271 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050449 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/050449
Accurate molecular barcoding Oct 26, 2022 Issued
Array ( [id] => 19614967 [patent_doc_number] => 20240400647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-05 [patent_title] => Biologically Active Collagen Hybridizing Peptides [patent_app_type] => utility [patent_app_number] => 18/698649 [patent_app_country] => US [patent_app_date] => 2022-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10589 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -52 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18698649 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/698649
Biologically Active Collagen Hybridizing Peptides Oct 6, 2022 Pending
17/819591 PREPARATION AND COMPOSITION OF INTER-ALPHA INHIBITOR PROTEINS FROM HUMAN PLASMA FOR THERAPEUTIC USE Aug 11, 2022 Pending
Array ( [id] => 20518705 [patent_doc_number] => 20260042809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-02-12 [patent_title] => PROCESS FOR THE PREPARATION OF SEMAGLUTIDE [patent_app_type] => utility [patent_app_number] => 18/294556 [patent_app_country] => US [patent_app_date] => 2022-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9773 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18294556 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/294556
PROCESS FOR THE PREPARATION OF SEMAGLUTIDE Aug 3, 2022 Pending
17/816448 Use of an All-D-Pentapeptide Chemokine Antagonist to Reduce Opioid Dose in a Person with Pain Jul 31, 2022 Abandoned
90/015080 SYSTEM, ARRAY AND NON-POROUS SOLID SUPPORT COMPRISING FIXED OR IMMOBILIZED NUCLEIC ACIDS Jul 25, 2022 Pending
17/869925 USE OF AN ALL-D-PENTAPEPTIDE CHEMOKINE ANTAGONIST TO REDUCE OPIOID DOSE IN A PERSON WITH PAIN Jul 20, 2022 Pending
Array ( [id] => 19496481 [patent_doc_number] => 20240335499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => PEPTIDE HAVING ANTIDIABETIC ACTIVITY AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/574406 [patent_app_country] => US [patent_app_date] => 2022-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5263 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18574406 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/574406
PEPTIDE HAVING ANTIDIABETIC ACTIVITY AND USE THEREOF Jun 27, 2022 Pending
Array ( [id] => 20670943 [patent_doc_number] => 12611438 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-04-28 [patent_title] => Antiviral composition comprising a nucleolin-binding peptide [patent_app_type] => utility [patent_app_number] => 18/549549 [patent_app_country] => US [patent_app_date] => 2022-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 15267 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549549 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/549549
Antiviral composition comprising a nucleolin-binding peptide May 17, 2022 Issued
17/739055 ANTI-BCMA ANTIBODIES AND USES THEREOF May 5, 2022 Pending
Array ( [id] => 20262209 [patent_doc_number] => RE050621 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-10-07 [patent_title] => Detecting breast cancer [patent_app_type] => reissue [patent_app_number] => 17/735477 [patent_app_country] => US [patent_app_date] => 2022-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42095 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735477 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/735477
Detecting breast cancer May 2, 2022 Issued
Array ( [id] => 18869883 [patent_doc_number] => 11857663 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-02 [patent_title] => Stable silk protein fragment compositions [patent_app_type] => utility [patent_app_number] => 17/716730 [patent_app_country] => US [patent_app_date] => 2022-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 105 [patent_figures_cnt] => 248 [patent_no_of_words] => 38010 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716730 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/716730
Stable silk protein fragment compositions Apr 7, 2022 Issued
Array ( [id] => 17748020 [patent_doc_number] => 20220226223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => Stable Silk Protein Fragment Compositions [patent_app_type] => utility [patent_app_number] => 17/716743 [patent_app_country] => US [patent_app_date] => 2022-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716743 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/716743
Stable silk protein fragment compositions Apr 7, 2022 Issued
Array ( [id] => 19417382 [patent_doc_number] => 20240293505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => REVERSAL OF CTL EXHAUSTION WITH ANNEXIN V [patent_app_type] => utility [patent_app_number] => 18/282152 [patent_app_country] => US [patent_app_date] => 2022-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10791 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282152 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/282152
REVERSAL OF CTL EXHAUSTION WITH ANNEXIN V Mar 28, 2022 Pending
Array ( [id] => 18700089 [patent_doc_number] => 11786575 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-17 [patent_title] => Endoparasitic depsipeptides [patent_app_type] => utility [patent_app_number] => 17/696955 [patent_app_country] => US [patent_app_date] => 2022-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53027 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17696955 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/696955
Endoparasitic depsipeptides Mar 16, 2022 Issued
Array ( [id] => 18140799 [patent_doc_number] => 20230014640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => CARBETOCIN DRUG PRODUCT AND PROCESS FOR PREPARING SAME [patent_app_type] => utility [patent_app_number] => 17/684742 [patent_app_country] => US [patent_app_date] => 2022-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19547 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17684742 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/684742
Agitation process for preparing a carbetocin drug product Mar 1, 2022 Issued
Menu